[Migraine: genetic, physiopathological, and therapeutic innovations].
Schoenen
J
J
Université de Liège, Département de Neurologie, CHR Citadelle.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000700:Analgesics / Q000627:therapeutic use; D001921:Brain / Q000503:physiopathology; D005071:Evoked Potentials / Q000502:physiology; D006579:Heterozygote; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy / Q000235:genetics / Q000503:physiopathology; D012256:Riboflavin / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000700:Analgesics; D012256:Riboflavin